ENXTPA:ALTUV

Stock Analysis Report

Executive Summary

BIO-UV Group S.A. manufactures and markets ultraviolet light water treatment equipment for individuals and professionals in France.

Snowflake

Fundamentals

High growth potential with mediocre balance sheet.

Share Price & News

How has BIO-UV Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ALTUV has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

7.2%

ALTUV

-0.7%

FR Machinery

0.9%

FR Market


1 Year Return

18.4%

ALTUV

-6.6%

FR Machinery

16.6%

FR Market

Return vs Industry: ALTUV exceeded the French Machinery industry which returned -6.6% over the past year.

Return vs Market: ALTUV exceeded the French Market which returned 16.6% over the past year.


Shareholder returns

ALTUVIndustryMarket
7 Day7.2%-0.7%0.9%
30 Day-3.0%-0.2%4.5%
90 Day-5.3%-0.4%10.6%
1 Year18.4%18.4%4.2%-6.6%20.5%16.6%
3 Yearn/a44.3%27.3%51.4%37.0%
5 Yearn/a32.5%16.6%68.8%45.0%

Price Volatility Vs. Market

How volatile is BIO-UV Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is BIO-UV Group undervalued compared to its fair value and its price relative to the market?

1.69x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: ALTUV (€3.58) is trading above our estimate of fair value (€3.13)

Significantly Below Fair Value: ALTUV is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: ALTUV is unprofitable, so we can't compare its PE Ratio to the Machinery industry average.

PE vs Market: ALTUV is unprofitable, so we can't compare its PE Ratio to the French market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ALTUV's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: ALTUV is overvalued based on its PB Ratio (1.7x) compared to the FR Machinery industry average (1.4x).


Next Steps

Future Growth

How is BIO-UV Group forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

98.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ALTUV is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.7%).

Earnings vs Market: ALTUV is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ALTUV's is expected to become profitable in the next 3 years.

Revenue vs Market: ALTUV's revenue (40% per year) is forecast to grow faster than the French market (4.6% per year).

High Growth Revenue: ALTUV's revenue (40% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ALTUV's Return on Equity is forecast to be low in 3 years time (14%).


Next Steps

Past Performance

How has BIO-UV Group performed over the past 5 years?

-382.0%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: ALTUV has a high level of non-cash earnings.

Growing Profit Margin: ALTUV's current net profit margins (-0.7%) are lower than last year (-0.2%).


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if ALTUV's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare ALTUV's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ALTUV is unprofitable, making it difficult to compare its past year earnings growth to the Machinery industry (-20.2%).


Return on Equity

High ROE: ALTUV has a negative Return on Equity (-0.67%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is BIO-UV Group's financial position?


Financial Position Analysis

Short Term Liabilities: ALTUV's short term assets (€14.5M) exceeds its short term liabilities (€6.2M)

Long Term Liabilities: ALTUV's short term assets (14.5M) exceeds its long term liabilities (6.1M)


Debt to Equity History and Analysis

Debt Level: ALTUV's debt to equity ratio (25%) is considered satisfactory

Reducing Debt: Insufficient data to determine if ALTUV's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: ALTUV's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if ALTUV's interest payments on its debt are well covered by EBIT.


Balance Sheet

Inventory Level: ALTUV has a high level of physical assets or inventory.

Debt Coverage by Assets: ALTUV's debt is covered by short term assets (assets are 3.5x debt).


Next Steps

Dividend

What is BIO-UV Group's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%4.5%industryaverage12.5%forecastin3Years0%

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate ALTUV's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate ALTUV's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ALTUV's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ALTUV's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ALTUV's dividend in 3 years as they are not forecast to pay a notable one for the French market.


Next Steps

Management

What is the CEO of BIO-UV Group's salary, the management and board of directors tenure and is there insider trading?


CEO

BIO-UV Group has no CEO, or we have no data on them.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 60%.


Management Team

  • Benoit Gillmann

    MD & Chairman

    • Tenure: 0yrs

Board Members

  • Yves Fonderflick

    Director

    • Tenure: 0yrs
  • Eric Bellet

    Director

    • Tenure: 0yrs

Company Information

BIO-UV Group S.A.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: BIO-UV Group S.A.
  • Ticker: ALTUV
  • Exchange: ENXTPA
  • Founded: 2000
  • Industry: Industrial Machinery
  • Sector: Capital Goods
  • Market Cap: €28.060m
  • Shares outstanding: 7.84m
  • Website: https://www.bio-uv.com

Number of Employees


Location

  • BIO-UV Group S.A.
  • 850 avenue Louis Medard
  • Lunel
  • Languedoc-Roussillon
  • 34400
  • France

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ALTUVENXTPA (Euronext Paris)YesCommon SharesFREURJul 2018

Biography

BIO-UV Group S.A. manufactures and markets ultraviolet light water treatment equipment for individuals and professionals in France. Its products are used in various applications, including automatic water  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/11/16 22:47
End of Day Share Price2019/11/15 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.